Magnetic Resonance Imaging Equipment Market

ID: MRFR/PCM/26018-HCR
100 Pages
Snehal Singh
Last Updated: April 06, 2026
Magnetic Resonance Imaging MRI Equipment Market Research Report: By Field Strength (0.5 Tesla, 1.5 Tesla, 3 Tesla, 7 Tesla, Ultra-high Field (Above 7 Tesla)), By Configuration (Open MRI, Closed MRI, Upright MRI), By Weight Capacity (Less than 200 lbs, 200-300 lbs, 300-400 lbs, Over 400 lbs), By Clinical Application (Neuroimaging, Musculoskeletal Imaging, Cardiovascular Imaging, Oncology Imaging, Gastrointestinal Imaging) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035
Magnetic Resonance Imaging Equipment Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)4.58%
2024 Market Size$ 10.59 Billion
2025 Market Size$ 11.08 Billion
2035 Market Size$ 17.34 Billion
Key Players
Siemens Healthineers
GE Healthcare
Philips Healthcare
Canon Medical Systems
Hitachi Medical Systems
Fujifilm Holdings Corporation
Trends
  • Technological Advancements
  • Rising Demand for Non-Invasive Procedures
  • Expansion in Emerging Markets
Opportunities
  • Expansion in Emerging Markets
  • Aging Population and Chronic Diseases
  • Rising Demand for Non-Invasive Procedures
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Packaging & Transport, BY Field Strength (USD Billion)
      1. 4.1.1 1.5 Tesla
      2. 4.1.2 3 Tesla
      3. 4.1.3 Ultra-high Field
    2. 4.2 Packaging & Transport, BY Configuration (USD Billion)
      1. 4.2.1 Open MRI
      2. 4.2.2 Closed MRI
      3. 4.2.3 Upright MRI
    3. 4.3 Packaging & Transport, BY Weight Capacity (USD Billion)
      1. 4.3.1 Less than 200 lbs
      2. 4.3.2 200-300 lbs
      3. 4.3.3 300-400 lbs
      4. 4.3.4 Over 400 lbs
    4. 4.4 Packaging & Transport, BY Clinical Application (USD Billion)
      1. 4.4.1 Neuroimaging
      2. 4.4.2 Musculoskeletal Imaging
      3. 4.4.3 Cardiovascular Imaging
      4. 4.4.4 Oncology Imaging
      5. 4.4.5 Gastrointestinal Imaging
    5. 4.5 Packaging & Transport, BY Region (USD Billion)
      1. 4.5.1 North America
        1. 4.5.1.1 US
        2. 4.5.1.2 Canada
      2. 4.5.2 Europe
        1. 4.5.2.1 Germany
        2. 4.5.2.2 UK
        3. 4.5.2.3 France
        4. 4.5.2.4 Russia
        5. 4.5.2.5 Italy
        6. 4.5.2.6 Spain
        7. 4.5.2.7 Rest of Europe
      3. 4.5.3 APAC
        1. 4.5.3.1 China
        2. 4.5.3.2 India
        3. 4.5.3.3 Japan
        4. 4.5.3.4 South Korea
        5. 4.5.3.5 Malaysia
        6. 4.5.3.6 Thailand
        7. 4.5.3.7 Indonesia
        8. 4.5.3.8 Rest of APAC
      4. 4.5.4 South America
        1. 4.5.4.1 Brazil
        2. 4.5.4.2 Mexico
        3. 4.5.4.3 Argentina
        4. 4.5.4.4 Rest of South America
      5. 4.5.5 MEA
        1. 4.5.5.1 GCC Countries
        2. 4.5.5.2 South Africa
        3. 4.5.5.3 Rest of MEA
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Packaging & Transport
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Packaging & Transport
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Siemens Healthineers (DE)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 GE Healthcare (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Philips Healthcare (NL)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Canon Medical Systems (JP)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Hitachi Medical Systems (JP)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Fujifilm Holdings Corporation (JP)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Bruker Corporation (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Esaote S.p.A. (IT)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Neusoft Medical Systems (CN)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 NORTH AMERICA MARKET ANALYSIS
    3. 6.3 US MARKET ANALYSIS BY FIELD STRENGTH
    4. 6.4 US MARKET ANALYSIS BY CONFIGURATION
    5. 6.5 US MARKET ANALYSIS BY WEIGHT CAPACITY
    6. 6.6 US MARKET ANALYSIS BY CLINICAL APPLICATION
    7. 6.7 CANADA MARKET ANALYSIS BY FIELD STRENGTH
    8. 6.8 CANADA MARKET ANALYSIS BY CONFIGURATION
    9. 6.9 CANADA MARKET ANALYSIS BY WEIGHT CAPACITY
    10. 6.10 CANADA MARKET ANALYSIS BY CLINICAL APPLICATION
    11. 6.11 EUROPE MARKET ANALYSIS
    12. 6.12 GERMANY MARKET ANALYSIS BY FIELD STRENGTH
    13. 6.13 GERMANY MARKET ANALYSIS BY CONFIGURATION
    14. 6.14 GERMANY MARKET ANALYSIS BY WEIGHT CAPACITY
    15. 6.15 GERMANY MARKET ANALYSIS BY CLINICAL APPLICATION
    16. 6.16 UK MARKET ANALYSIS BY FIELD STRENGTH
    17. 6.17 UK MARKET ANALYSIS BY CONFIGURATION
    18. 6.18 UK MARKET ANALYSIS BY WEIGHT CAPACITY
    19. 6.19 UK MARKET ANALYSIS BY CLINICAL APPLICATION
    20. 6.20 FRANCE MARKET ANALYSIS BY FIELD STRENGTH
    21. 6.21 FRANCE MARKET ANALYSIS BY CONFIGURATION
    22. 6.22 FRANCE MARKET ANALYSIS BY WEIGHT CAPACITY
    23. 6.23 FRANCE MARKET ANALYSIS BY CLINICAL APPLICATION
    24. 6.24 RUSSIA MARKET ANALYSIS BY FIELD STRENGTH
    25. 6.25 RUSSIA MARKET ANALYSIS BY CONFIGURATION
    26. 6.26 RUSSIA MARKET ANALYSIS BY WEIGHT CAPACITY
    27. 6.27 RUSSIA MARKET ANALYSIS BY CLINICAL APPLICATION
    28. 6.28 ITALY MARKET ANALYSIS BY FIELD STRENGTH
    29. 6.29 ITALY MARKET ANALYSIS BY CONFIGURATION
    30. 6.30 ITALY MARKET ANALYSIS BY WEIGHT CAPACITY
    31. 6.31 ITALY MARKET ANALYSIS BY CLINICAL APPLICATION
    32. 6.32 SPAIN MARKET ANALYSIS BY FIELD STRENGTH
    33. 6.33 SPAIN MARKET ANALYSIS BY CONFIGURATION
    34. 6.34 SPAIN MARKET ANALYSIS BY WEIGHT CAPACITY
    35. 6.35 SPAIN MARKET ANALYSIS BY CLINICAL APPLICATION
    36. 6.36 REST OF EUROPE MARKET ANALYSIS BY FIELD STRENGTH
    37. 6.37 REST OF EUROPE MARKET ANALYSIS BY CONFIGURATION
    38. 6.38 REST OF EUROPE MARKET ANALYSIS BY WEIGHT CAPACITY
    39. 6.39 REST OF EUROPE MARKET ANALYSIS BY CLINICAL APPLICATION
    40. 6.40 APAC MARKET ANALYSIS
    41. 6.41 CHINA MARKET ANALYSIS BY FIELD STRENGTH
    42. 6.42 CHINA MARKET ANALYSIS BY CONFIGURATION
    43. 6.43 CHINA MARKET ANALYSIS BY WEIGHT CAPACITY
    44. 6.44 CHINA MARKET ANALYSIS BY CLINICAL APPLICATION
    45. 6.45 INDIA MARKET ANALYSIS BY FIELD STRENGTH
    46. 6.46 INDIA MARKET ANALYSIS BY CONFIGURATION
    47. 6.47 INDIA MARKET ANALYSIS BY WEIGHT CAPACITY
    48. 6.48 INDIA MARKET ANALYSIS BY CLINICAL APPLICATION
    49. 6.49 JAPAN MARKET ANALYSIS BY FIELD STRENGTH
    50. 6.50 JAPAN MARKET ANALYSIS BY CONFIGURATION
    51. 6.51 JAPAN MARKET ANALYSIS BY WEIGHT CAPACITY
    52. 6.52 JAPAN MARKET ANALYSIS BY CLINICAL APPLICATION
    53. 6.53 SOUTH KOREA MARKET ANALYSIS BY FIELD STRENGTH
    54. 6.54 SOUTH KOREA MARKET ANALYSIS BY CONFIGURATION
    55. 6.55 SOUTH KOREA MARKET ANALYSIS BY WEIGHT CAPACITY
    56. 6.56 SOUTH KOREA MARKET ANALYSIS BY CLINICAL APPLICATION
    57. 6.57 MALAYSIA MARKET ANALYSIS BY FIELD STRENGTH
    58. 6.58 MALAYSIA MARKET ANALYSIS BY CONFIGURATION
    59. 6.59 MALAYSIA MARKET ANALYSIS BY WEIGHT CAPACITY
    60. 6.60 MALAYSIA MARKET ANALYSIS BY CLINICAL APPLICATION
    61. 6.61 THAILAND MARKET ANALYSIS BY FIELD STRENGTH
    62. 6.62 THAILAND MARKET ANALYSIS BY CONFIGURATION
    63. 6.63 THAILAND MARKET ANALYSIS BY WEIGHT CAPACITY
    64. 6.64 THAILAND MARKET ANALYSIS BY CLINICAL APPLICATION
    65. 6.65 INDONESIA MARKET ANALYSIS BY FIELD STRENGTH
    66. 6.66 INDONESIA MARKET ANALYSIS BY CONFIGURATION
    67. 6.67 INDONESIA MARKET ANALYSIS BY WEIGHT CAPACITY
    68. 6.68 INDONESIA MARKET ANALYSIS BY CLINICAL APPLICATION
    69. 6.69 REST OF APAC MARKET ANALYSIS BY FIELD STRENGTH
    70. 6.70 REST OF APAC MARKET ANALYSIS BY CONFIGURATION
    71. 6.71 REST OF APAC MARKET ANALYSIS BY WEIGHT CAPACITY
    72. 6.72 REST OF APAC MARKET ANALYSIS BY CLINICAL APPLICATION
    73. 6.73 SOUTH AMERICA MARKET ANALYSIS
    74. 6.74 BRAZIL MARKET ANALYSIS BY FIELD STRENGTH
    75. 6.75 BRAZIL MARKET ANALYSIS BY CONFIGURATION
    76. 6.76 BRAZIL MARKET ANALYSIS BY WEIGHT CAPACITY
    77. 6.77 BRAZIL MARKET ANALYSIS BY CLINICAL APPLICATION
    78. 6.78 MEXICO MARKET ANALYSIS BY FIELD STRENGTH
    79. 6.79 MEXICO MARKET ANALYSIS BY CONFIGURATION
    80. 6.80 MEXICO MARKET ANALYSIS BY WEIGHT CAPACITY
    81. 6.81 MEXICO MARKET ANALYSIS BY CLINICAL APPLICATION
    82. 6.82 ARGENTINA MARKET ANALYSIS BY FIELD STRENGTH
    83. 6.83 ARGENTINA MARKET ANALYSIS BY CONFIGURATION
    84. 6.84 ARGENTINA MARKET ANALYSIS BY WEIGHT CAPACITY
    85. 6.85 ARGENTINA MARKET ANALYSIS BY CLINICAL APPLICATION
    86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY FIELD STRENGTH
    87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY CONFIGURATION
    88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY WEIGHT CAPACITY
    89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY CLINICAL APPLICATION
    90. 6.90 MEA MARKET ANALYSIS
    91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY FIELD STRENGTH
    92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY CONFIGURATION
    93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY WEIGHT CAPACITY
    94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY CLINICAL APPLICATION
    95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY FIELD STRENGTH
    96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY CONFIGURATION
    97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY WEIGHT CAPACITY
    98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY CLINICAL APPLICATION
    99. 6.99 REST OF MEA MARKET ANALYSIS BY FIELD STRENGTH
    100. 6.100 REST OF MEA MARKET ANALYSIS BY CONFIGURATION
    101. 6.101 REST OF MEA MARKET ANALYSIS BY WEIGHT CAPACITY
    102. 6.102 REST OF MEA MARKET ANALYSIS BY CLINICAL APPLICATION
    103. 6.103 KEY BUYING CRITERIA OF PACKAGING & TRANSPORT
    104. 6.104 RESEARCH PROCESS OF MRFR
    105. 6.105 DRO ANALYSIS OF PACKAGING & TRANSPORT
    106. 6.106 DRIVERS IMPACT ANALYSIS: PACKAGING & TRANSPORT
    107. 6.107 RESTRAINTS IMPACT ANALYSIS: PACKAGING & TRANSPORT
    108. 6.108 SUPPLY / VALUE CHAIN: PACKAGING & TRANSPORT
    109. 6.109 PACKAGING & TRANSPORT, BY FIELD STRENGTH, 2024 (% SHARE)
    110. 6.110 PACKAGING & TRANSPORT, BY FIELD STRENGTH, 2024 TO 2035 (USD Billion)
    111. 6.111 PACKAGING & TRANSPORT, BY CONFIGURATION, 2024 (% SHARE)
    112. 6.112 PACKAGING & TRANSPORT, BY CONFIGURATION, 2024 TO 2035 (USD Billion)
    113. 6.113 PACKAGING & TRANSPORT, BY WEIGHT CAPACITY, 2024 (% SHARE)
    114. 6.114 PACKAGING & TRANSPORT, BY WEIGHT CAPACITY, 2024 TO 2035 (USD Billion)
    115. 6.115 PACKAGING & TRANSPORT, BY CLINICAL APPLICATION, 2024 (% SHARE)
    116. 6.116 PACKAGING & TRANSPORT, BY CLINICAL APPLICATION, 2024 TO 2035 (USD Billion)
    117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
      2. 7.2.2 BY CONFIGURATION, 2025-2035 (USD Billion)
      3. 7.2.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
      4. 7.2.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
    2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.3.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
      2. 7.3.2 BY CONFIGURATION, 2025-2035 (USD Billion)
      3. 7.3.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
      4. 7.3.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
    3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
      1. 7.4.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
      2. 7.4.2 BY CONFIGURATION, 2025-2035 (USD Billion)
      3. 7.4.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
      4. 7.4.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
    4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.5.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
      2. 7.5.2 BY CONFIGURATION, 2025-2035 (USD Billion)
      3. 7.5.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
      4. 7.5.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
    5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
      1. 7.6.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
      2. 7.6.2 BY CONFIGURATION, 2025-2035 (USD Billion)
      3. 7.6.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
      4. 7.6.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
    6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
      1. 7.7.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
      2. 7.7.2 BY CONFIGURATION, 2025-2035 (USD Billion)
      3. 7.7.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
      4. 7.7.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
    7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
      1. 7.8.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
      2. 7.8.2 BY CONFIGURATION, 2025-2035 (USD Billion)
      3. 7.8.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
      4. 7.8.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
    8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
      1. 7.9.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
      2. 7.9.2 BY CONFIGURATION, 2025-2035 (USD Billion)
      3. 7.9.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
      4. 7.9.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
    9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
      1. 7.10.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
      2. 7.10.2 BY CONFIGURATION, 2025-2035 (USD Billion)
      3. 7.10.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
      4. 7.10.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
    10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
      1. 7.11.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
      2. 7.11.2 BY CONFIGURATION, 2025-2035 (USD Billion)
      3. 7.11.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
      4. 7.11.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
    11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.12.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
      2. 7.12.2 BY CONFIGURATION, 2025-2035 (USD Billion)
      3. 7.12.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
      4. 7.12.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
    12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.13.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
      2. 7.13.2 BY CONFIGURATION, 2025-2035 (USD Billion)
      3. 7.13.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
      4. 7.13.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
    13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.14.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
      2. 7.14.2 BY CONFIGURATION, 2025-2035 (USD Billion)
      3. 7.14.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
      4. 7.14.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
    14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.15.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
      2. 7.15.2 BY CONFIGURATION, 2025-2035 (USD Billion)
      3. 7.15.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
      4. 7.15.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
    15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
      1. 7.16.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
      2. 7.16.2 BY CONFIGURATION, 2025-2035 (USD Billion)
      3. 7.16.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
      4. 7.16.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
    16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
      1. 7.17.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
      2. 7.17.2 BY CONFIGURATION, 2025-2035 (USD Billion)
      3. 7.17.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
      4. 7.17.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
    17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. 7.18.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
      2. 7.18.2 BY CONFIGURATION, 2025-2035 (USD Billion)
      3. 7.18.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
      4. 7.18.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
    18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
      1. 7.19.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
      2. 7.19.2 BY CONFIGURATION, 2025-2035 (USD Billion)
      3. 7.19.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
      4. 7.19.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
    19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. 7.20.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
      2. 7.20.2 BY CONFIGURATION, 2025-2035 (USD Billion)
      3. 7.20.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
      4. 7.20.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
    20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.21.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
      2. 7.21.2 BY CONFIGURATION, 2025-2035 (USD Billion)
      3. 7.21.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
      4. 7.21.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
    21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.22.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
      2. 7.22.2 BY CONFIGURATION, 2025-2035 (USD Billion)
      3. 7.22.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
      4. 7.22.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
    22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
      1. 7.23.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
      2. 7.23.2 BY CONFIGURATION, 2025-2035 (USD Billion)
      3. 7.23.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
      4. 7.23.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
    23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
      1. 7.24.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
      2. 7.24.2 BY CONFIGURATION, 2025-2035 (USD Billion)
      3. 7.24.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
      4. 7.24.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
    24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
      1. 7.25.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
      2. 7.25.2 BY CONFIGURATION, 2025-2035 (USD Billion)
      3. 7.25.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
      4. 7.25.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
    25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.26.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
      2. 7.26.2 BY CONFIGURATION, 2025-2035 (USD Billion)
      3. 7.26.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
      4. 7.26.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
    26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.27.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
      2. 7.27.2 BY CONFIGURATION, 2025-2035 (USD Billion)
      3. 7.27.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
      4. 7.27.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
    27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. 7.28.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
      2. 7.28.2 BY CONFIGURATION, 2025-2035 (USD Billion)
      3. 7.28.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
      4. 7.28.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
    28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
      1. 7.29.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
      2. 7.29.2 BY CONFIGURATION, 2025-2035 (USD Billion)
      3. 7.29.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
      4. 7.29.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
    29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.30.1 BY FIELD STRENGTH, 2025-2035 (USD Billion)
      2. 7.30.2 BY CONFIGURATION, 2025-2035 (USD Billion)
      3. 7.30.3 BY WEIGHT CAPACITY, 2025-2035 (USD Billion)
      4. 7.30.4 BY CLINICAL APPLICATION, 2025-2035 (USD Billion)
    30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.31.1
    1. 7.32 ACQUISITION/PARTNERSHIP
  10. 7.32.1

Magnetic Resonance Imaging Equipment Market Segmentation

Magnetic Resonance Imaging Equipment Market By Field Strength (USD Billion, 2025-2035)

  • 1.5 Tesla
  • 3 Tesla
  • Ultra-high Field

Magnetic Resonance Imaging Equipment Market By Configuration (USD Billion, 2025-2035)

  • Open MRI
  • Closed MRI
  • Upright MRI

Magnetic Resonance Imaging Equipment Market By Weight Capacity (USD Billion, 2025-2035)

  • Less than 200 lbs
  • 200-300 lbs
  • 300-400 lbs
  • Over 400 lbs

Magnetic Resonance Imaging Equipment Market By Clinical Application (USD Billion, 2025-2035)

  • Neuroimaging
  • Musculoskeletal Imaging
  • Cardiovascular Imaging
  • Oncology Imaging
  • Gastrointestinal Imaging

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.